Session 3: Is there a need to change first-line therapies?
Moderator: Waleed Ghanima, Oslo, Norway
Lecture 3.1: Deirdra R. Terrell, Oklahoma City, USA: What are the needs of patients with ITP?
Lecture 3.2: Cindy Neunert New York USA: Limitations of current therapies for patients with newly-diagnosed ITP
Lecture 3.3: Katja Heitink-Pollé Utrecht, The Netherlands: Is there a need to re-consider the management of patients with newly-diagnosed ITP?
Lecture 3.4: Nichola Cooper London, UK: Therapy-refractory ITP
Discussion 3.5: Moderator: Waleed Ghanima, Oslo, Norway: Moderation of Discussion of Session 3
All speakers, moderators, and discussants